Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesGSKs Cervarix becomes the first cervical cancer vaccine to gain approval in Japan
GlaxoSmithKline, 10/19/09
GlaxoSmithKline gained approval for Cervarix in Japan, which becomes the first cervical cancer vaccine to be approved by the Japanese Ministry of Health, Labour and Welfare. This approval marks a significant milestone for GSK, as Cervarix will be the first vaccine to be launched by the company’s Japanese business.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Amylin Pharmaceuticals, 03/16/10
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis - Bayer Healthcare Pharmaceuticals
Bayer HealthCare Pharmaceuticals, 03/15/10
FDA Approves Boston Scientifics Express LD Iliac Stent System
Boston Scientific, 03/12/10
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
EVITA: a tool for the early EValuation of pharmaceutical Innovations with regard to Therapeutic Advantage
BMC Clinical Pharmacology, 03/17/10
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Amylin Pharmaceuticals, 03/16/10
FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy
Medtronic, 03/15/10
Article Search
Sponsor
Sponsor